Close Menu

NEW YORK (GenomeWeb) ― New Zealand startup Ubiquitome and custom oligo supplier Integrated DNA Technologies (IDT) announced a new partnership today to develop a hand-held Ebola assay.

The assay will be developed by IDT using the firm's PrimeTime qPCR Assay components. It will run on Ubiquitome's hand-held PCR platform, the Freedom4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.